Physician profile
Jonathan Mahram
NPI 1366978306
$812.45
in general payments reported to CMS, 2019-2025
17 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.40 · 2021: $25.47 · 2022: $220 · 2023: $140 · 2024: $163 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $156.32 | 2021-2024 | |
| Intuitive Surgical, INC. | $111.64 | 2022 | |
| Organon LLC | $80.38 | 2023-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $80.04 | 2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Aptima |
| Sage Therapeutics, LLC | $64.32 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $52.99 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $48.12 | 2022-2023 | |
| Minerva Surgical, INC | $34.06 | 2023-2025 | |
| Pfizer INC. | $29.84 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $29.31 | 2023-2024 | Myfembree, Gemtesa |
| Cgg Medical INC | $25.50 | 2025 | |
| Coopersurgical, INC. | $22.45 | 2025 | Endosee |
| Supernus Pharmaceuticals, INC. | $18.99 | 2025 | Qelbree |
| Astellas Pharma US INC | $17.22 | 2024 | Veozah |
| Ethicon US, LLC | $14.59 | 2025 | Enseal |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13.40 | 2019 | |
| Evofem Biosciences, INC. | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mahram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.